Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
- PMID: 37365502
- PMCID: PMC10291812
- DOI: 10.1186/s10020-023-00675-w
Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
Abstract
c-Jun activation domain binding protein-1 (JAB1) is a multifunctional regulator that plays vital roles in diverse cellular processes. It regulates AP-1 transcriptional activity and also acts as the fifth component of the COP9 signalosome complex. While JAB1 is considered an oncoprotein that triggers tumor development, recent studies have shown that it also functions in neurological development and disorders. In this review, we summarize the general features of the JAB1 gene and protein, and present recent updates on the regulation of JAB1 expression. Moreover, we also highlight the functional roles and regulatory mechanisms of JAB1 in neurodevelopmental processes such as neuronal differentiation, synaptic morphogenesis, myelination, and hair cell development and in the pathogenesis of some neurological disorders such as Alzheimer's disease, multiple sclerosis, neuropathic pain, and peripheral nerve injury. Furthermore, current challenges and prospects are discussed, including updates on drug development targeting JAB1.
Keywords: COP9 signalosome; Neurodevelopment; Neurological disorders; Regulatory mechanisms; c-Jun activation domain binding protein-1.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.Breast Cancer Res. 2011 Jun 20;13(3):R65. doi: 10.1186/bcr2902. Breast Cancer Res. 2011. PMID: 21689417 Free PMC article.
-
Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome.Anticancer Agents Med Chem. 2019;19(16):2019-2033. doi: 10.2174/1871520619666190725122400. Anticancer Agents Med Chem. 2019. PMID: 31345154
-
Jab1/Cops5: a promising target for cancer diagnosis and therapy.Int J Clin Oncol. 2021 Jul;26(7):1159-1169. doi: 10.1007/s10147-021-01933-9. Epub 2021 May 21. Int J Clin Oncol. 2021. PMID: 34019195 Review.
-
JAB1/CSN5 and the COP9 signalosome. A complex situation.EMBO Rep. 2001 Feb;2(2):96-101. doi: 10.1093/embo-reports/kve028. EMBO Rep. 2001. PMID: 11258719 Free PMC article. Review.
-
Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.Cancer Biol Ther. 2014 Mar 1;15(3):256-62. doi: 10.4161/cbt.27823. Epub 2014 Feb 4. Cancer Biol Ther. 2014. PMID: 24495954 Free PMC article. Review.
Cited by
-
Integrative analysis of serum proteomics and transcriptomics in hepatitis C.Virol J. 2025 Mar 13;22(1):73. doi: 10.1186/s12985-025-02690-1. Virol J. 2025. PMID: 40082995 Free PMC article.
-
Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities.Neurotherapeutics. 2025 Apr;22(3):e00519. doi: 10.1016/j.neurot.2024.e00519. Epub 2025 Jan 6. Neurotherapeutics. 2025. PMID: 39765417 Free PMC article. Review.
-
Oxidative Stress-Mediated RUNX3 Mislocalization Occurs Via Jun Activation Domain-Binding Protein 1 and Histone Modification.Appl Biochem Biotechnol. 2024 Nov;196(11):8082-8095. doi: 10.1007/s12010-024-04944-0. Epub 2024 Apr 29. Appl Biochem Biotechnol. 2024. PMID: 38683453 Free PMC article.
-
Shared interactions of six neurotropic viruses with 38 human proteins: a computational and literature-based exploration of viral interactions and hijacking of human proteins in neuropsychiatric disorders.Discov Ment Health. 2025 Feb 22;5(1):18. doi: 10.1007/s44192-025-00128-2. Discov Ment Health. 2025. PMID: 39987419 Free PMC article.
References
-
- Altmann E, Erbel P, Renatus M, Schaefer M, Schlierf A, Druet A, Kieffer L, Sorge M, Pfister K, Hassiepen U, Jones M, Ruedisser S, Ostermeier D, Martoglio B, Jefferson AB, Quancard J. Azaindoles as zinc-binding small-molecule inhibitors of the JAMM protease CSN5. Angew Chem Int Ed Engl. 2017;56:1294–1297. doi: 10.1002/anie.201608672. - DOI - PubMed
-
- Alvites R, Rita Caseiro A, Santos Pedrosa S, Vieira Branquinho M, Ronchi G, Geuna S, Varejão ASP, Colette Maurício A. Peripheral nerve injury and axonotmesis: state of the art and recent advances. Cogent Med. 2018;5:1466404. doi: 10.1080/2331205X.2018.1466404. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous